Research ArticleHuman Studies
Initial Clinical Evaluation of Iodine-125-Labeled Chimeric 17-lA for Metastatic Colon Cancer
Ruby F. Meredith, M.B. Khazaeli, Walter E. Plott, Sharon A. Spencer, Richard H. Wheeler, Luther W. Brady, David V. Woo and Albert F. LoBuglio
Journal of Nuclear Medicine December 1995, 36 (12) 2229-2233;
Ruby F. Meredith
M.B. Khazaeli
Walter E. Plott
Sharon A. Spencer
Richard H. Wheeler
Luther W. Brady
David V. Woo


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Initial Clinical Evaluation of Iodine-125-Labeled Chimeric 17-lA for Metastatic Colon Cancer
Ruby F. Meredith, M.B. Khazaeli, Walter E. Plott, Sharon A. Spencer, Richard H. Wheeler, Luther W. Brady, David V. Woo, Albert F. LoBuglio
Journal of Nuclear Medicine Dec 1995, 36 (12) 2229-2233;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Current Status of Therapy of Solid Tumors
- Radiolabeling of Avidin with Very High Specific Activity for Internal Radiation Therapy of Intraperitoneally Disseminated Tumors
- High-Linear Energy Transfer (LET) {{alpha}} versus Low-LET {beta} Emitters in Radioimmunotherapy of Solid Tumors: Therapeutic Efficacy and Dose-limiting Toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' Fragments in a Human Colonic Cancer Model